S&P 500   3,004.52 (+0.28%)
DOW   26,833.95 (+0.17%)
QQQ   192.22 (+0.19%)
AAPL   243.18 (+1.34%)
FB   186.19 (+2.11%)
MSFT   137.24 (+0.64%)
GOOGL   1,257.63 (+1.32%)
AMZN   1,762.17 (-0.20%)
CGC   21.75 (+2.84%)
NVDA   195.09 (-0.27%)
MU   44.66 (+0.00%)
BABA   169.92 (+0.02%)
GE   9.14 (+0.88%)
TSLA   254.68 (-0.35%)
AMD   31.36 (-0.48%)
T   37.74 (-1.13%)
F   9.21 (+1.54%)
ACB   3.67 (+2.51%)
PRI   125.75 (-0.04%)
NFLX   271.27 (+1.72%)
BAC   31.42 (+0.71%)
GILD   66.58 (+1.09%)
DIS   131.13 (-0.96%)
S&P 500   3,004.52 (+0.28%)
DOW   26,833.95 (+0.17%)
QQQ   192.22 (+0.19%)
AAPL   243.18 (+1.34%)
FB   186.19 (+2.11%)
MSFT   137.24 (+0.64%)
GOOGL   1,257.63 (+1.32%)
AMZN   1,762.17 (-0.20%)
CGC   21.75 (+2.84%)
NVDA   195.09 (-0.27%)
MU   44.66 (+0.00%)
BABA   169.92 (+0.02%)
GE   9.14 (+0.88%)
TSLA   254.68 (-0.35%)
AMD   31.36 (-0.48%)
T   37.74 (-1.13%)
F   9.21 (+1.54%)
ACB   3.67 (+2.51%)
PRI   125.75 (-0.04%)
NFLX   271.27 (+1.72%)
BAC   31.42 (+0.71%)
GILD   66.58 (+1.09%)
DIS   131.13 (-0.96%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 EpizymeZymeworksEsperion TherapeuticsAmphastar PharmaceuticalsDicerna Pharmaceuticals
SymbolNASDAQ:EPZMNYSE:ZYMENASDAQ:ESPRNASDAQ:AMPHNASDAQ:DRNA
Price Information
Current Price$10.85$30.16$39.16$19.95$16.12
52 Week RangeBuyBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$17.50$36.57$70.44$25.05$23.00
% Upside from Price Target61.29% upside21.26% upside79.89% upside25.56% upside42.68% upside
Trade Information
Market Cap$977.73 million$1.20 billion$1.07 billion$942.71 million$1.11 billion
Beta2.371.341.891.142.21
Average Volume803,338214,218509,804195,115452,754
Sales & Book Value
Annual Revenue$21.70 million$53.02 millionN/A$294.67 million$6.18 million
Price / Sales45.5222.36N/A3.20178.31
CashflowN/AN/AN/A$0.58 per shareN/A
Price / CashN/AN/AN/A34.24N/A
Book Value$2.94 per share$5.64 per share$2.95 per share$7.90 per share$3.20 per share
Price / Book3.695.35N/A2.535.04
Profitability
Net Income$-123,630,000.00$-36,560,000.00$-201,810,000.00$-5,740,000.00$-88,850,000.00
EPS($1.72)($1.26)($7.54)$0.21($1.20)
Trailing P/E RatioN/AN/AN/A95.00N/A
Forward P/E RatioN/AN/AN/A21.68N/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-102.78%N/A16.33%-737.93%
Return on Equity (ROE)-54.00%-24.44%-59.62%5.52%-50.30%
Return on Assets (ROA)-43.79%-19.13%-35.60%3.92%-26.16%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.03%0.02%0.01%0.13%0.01%
Current Ratio10.56%9.07%5.65%2.81%3.65%
Quick Ratio10.56%9.07%5.65%1.83%3.65%
Ownership Information
Institutional Ownership Percentage86.30%49.87%N/A47.32%82.04%
Insider Ownership Percentage16.60%4.80%7.70%30.80%21.28%
Miscellaneous
Employees124180762,07878
Shares Outstanding91.04 million39.31 million27.17 million47.23 million68.36 million
Next Earnings Date11/1/2019 (Estimated)11/5/2019 (Estimated)11/7/2019 (Estimated)11/14/2019 (Estimated)11/4/2019 (Estimated)
OptionableOptionableOptionableOptionableOptionableOptionable
 EpizymeZymeworksEsperion TherapeuticsAmphastar PharmaceuticalsDicerna Pharmaceuticals

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel